Special Populations

What is new in research on anxiety symptoms and disorders?

In this CME, review the risks and clinical implications of intimate partner violence on women’s substance use and treatment.

From sleep disturbances in ADHD to psychotherapy for treatment-resistant depression, here are highlights from the week in Psychiatric Times.

It is Transgender Awareness Week. Here’s what you need to know as a clinician.

About 1 in 6 of Medicare patients report trouble paying Medicare bills and debt.

What is the impact of ADHD on sleep? Researchers performed a systematic review and meta-analysis of objectively measured sleep in children and adolescents with ADHD.

"In regard to psychiatric hospitalizations, the principles of ethics are imperative in determining how to proceed in each case."

The experts weighed in on a wide variety of psychiatric issues for the October 2023 issue of Psychiatric Times.

The mental health workforce remains predominantly White, despite slight progress towards more diversity. Here’s how we can remove barriers for individuals of color who wish to enter the mental health field.

Our older adults deserve respect and proper medical care, just as much as younger patients.

“Epidemiological surveys have shown that gender gaps and alcohol consumption and alcohol-related harms are narrowing for women and men—such that alcohol is growing women’s health issue.”

What is new in research on schizophrenia?

New data from the Suicide and Trauma Reduction Initiative for Veterans at Ohio State University indicates the most effective interventions to prevent suicide risk among veterans.

A time of year to celebrate and protect mental health.

From new research on treatment-resistant major depression to strategies for supporting trauma-affected refugee youth, here are highlights from the week in Psychiatric Times.

What is new in research on depression?

The experts weighed in on a wide variety of psychiatric issues for the September 2023 issue of Psychiatric Times.

From violence risk assessment in emergency departments to connections between bipolar disorder and substance use disorders, here are highlights from the week in Psychiatric Times.

How can we ensure that diversity, equity, inclusion, and access are truly achieved in clinical trials industry-wide?

The presentation of schizophrenia differs significantly between men and women. Here's what you need to know.

What is new in research on psychiatric care for Latinx patient populations?

September 15 to October 15 is Hispanic Heritage Month. To celebrate, here’s a look at some recent coverage in Psychiatric Times® on how clinicians can improve psychiatric care for Latinx patients.

From cannabis use disorder and schizophrenia to social media use and youth mental health, here are highlights from the week in Psychiatric Times.

What is new in research on attention-deficit/hyperactivity disorder?

As we commemorate the landmark March on Washington, parallels are drawn between Dr Martin Luther King Jr's dreams of equality and the goals of social psychiatry, highlighting the need to address social determinants of mental health.

From TMS as a treatment for long COVID to an update on 988 and crisis care, here are highlights from the week in Psychiatric Times.

According to the National Community Pharmacists Association, 97% of independent pharmacy owners reported shortages of Adderall in early 2023. As these shortages continue, here's how you can best support your patients with ADHD.

From overutilization of emergency departments to reversible clomiphene-associated manic episodes, here are highlights from the week in Psychiatric Times.

The FDA did not grant approval for the treatment for major depressive disorder.